# Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients

> **NCT03743025** · PHASE4 · TERMINATED · sponsor: **Emory University** · enrollment: 28 (actual)

## Conditions studied

- Stress Hyperglycemia

## Interventions

- **DRUG:** Dulaglutide Injection
- **OTHER:** Saline Injection

## Key facts

- **NCT ID:** NCT03743025
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-08
- **Primary completion:** 2023-05-02
- **Final completion:** 2023-05-02
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** The study was terminated following the Data and Safety Monitoring Board (DSMB) review due to concerns with perioperative use of the study drug.
- **Last updated:** 2024-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03743025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03743025, "Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03743025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*